Abnormal fluid flow can exacerbate or mitigate toxicity. For example, congestive heart failure can reduce blood flow, potentially leading to decreased toxin clearance and increased toxicity. Conversely, increased blood flow might enhance the distribution and clearance of a toxin, reducing its toxic effects. Understanding these dynamics is crucial for managing clinical toxicology cases.
